RF Industries Appoints Seasoned Financial Executive Mark Holdsworth to Board of Directors
SAN DIEGO, CA / ACCESSWIRE / January 5, 2021 / RF Industries, Ltd. (NASDAQ:RFIL), a…
SAN DIEGO, CA / ACCESSWIRE / January 5, 2021 / RF Industries, Ltd. (NASDAQ:RFIL), a…
NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. (“Elite” or the…
VANCOUVER, BC / ACCESSWIRE / January 5, 2021 / Snipp Interactive Inc. (“Snipp”, the “Company”)…
Affordable Medical-Grade Nitrile Exam Gloves to Be Distributed to US Market During 2021 Q1 NEW…
MONTREAL, QC / ACCESSWIRE / January 5, 2021 / Amex Exploration Inc. (“Amex or the…
TORONTO, ON / ACCESSWIRE / January 5, 2021Â / Roscan Gold Corporation (“Roscan” or the “Company”)…
LOS ANGELES, CA / ACCESSWIRE / January 5, 2021 / You probably read a lot…
“Establishing a sustainable recycling system… Improving the local community environment and helping residents to become…
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN…
The COVID-19 Pandemic has interestingly led to an uptick in the use and interest in…
Funds advised by Hilltop Credit Partners Limited (“Hilltop”) have provided a development finance facility of…
PRESS RELEASE Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a…
ALLSCHWIL, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) announced today that…
LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye…
IPH6101/SAR443579 is an NKp46-based NK cell engager (NKCE) that uses Innate’s proprietary multispecific antibody format…
Press Release Nicox Highlights Successful 2020 Development Progress and Clinical Milestones for 2021 Â Initiated…
COPENHAGEN, Denmark, January 5, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
Investors can pre-register for the event here LAUSANNE, Switzerland, Jan. 05, 2021 (GLOBE NEWSWIRE) —…
Tiragolumab is the first anti-TIGIT therapy to be granted Breakthrough Therapy Designation (BTD) and marks…